Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine
4 Mins read
Coalition for Epidemic Preparedness Innovations (CEPI) partnership will support Themis’ development and manufacturing of vaccine candidate — Vienna, Austria and Oslo, Norway,…